• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by AdvanSix Inc.

    5/16/25 5:16:37 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    DEFA14A 1 defa14amay162025.htm DEFA14A Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 14A
     
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No.      )  
    Filed by the Registrant x
    Filed by a party other than the Registrant o
    Check the appropriate box:
    o
    Preliminary Proxy Statement
    oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    oDefinitive Proxy Statement
    x
    Definitive Additional Materials
    oSoliciting Material under §240.14a-12
    AdvanSix Inc.
    (Name of Registrant as Specified In Its Charter)
     
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
     
    Payment of Filing Fee (Check all boxes that apply):
    xNo fee required.
    o
    Fee paid previously with preliminary materials.
    o
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.







    imagea.jpg

    300 Kimball Drive, Suite 101
    Parsippany, New Jersey 07054

    PROXY STATEMENT SUPPLEMENT

    This supplement (this “Supplement”) supplements the definitive proxy statement filed by AdvanSix Inc. (the “Company”) with the U.S. Securities and Exchange Commission (“SEC”) on April 29, 2025 (the “2025 Proxy Statement”) and made available to the Company’s stockholders in connection with the solicitation of proxies by the Company’s Board of Directors (the “Board”) for use at the 2025 Annual Meeting of Stockholders, to be held virtually on Wednesday, June 18, 2025 at 9:00 a.m., Eastern Time (the “Annual Meeting”). This Supplement is being filed with the SEC and made available to stockholders on or about May 16, 2025.

    This Supplement is being filed to update the disclosure in the 2025 Proxy Statement under the heading “Voting Procedures — Quorum; Vote Required; Abstentions and Broker Non-Votes” to revise the description of the impact of abstentions on each of Proposal Nos. 2, 3, and 4 in the 2025 Proxy Statement. That section is hereby revised in its entirety to read as follows:

    QUORUM; VOTE REQUIRED; ABSTENTIONS AND BROKER NON-VOTES

    The required quorum for the transaction of business at the meeting is a majority of the total outstanding shares of Common Stock entitled to vote at the meeting, either present at the Annual Meeting or represented by proxy. Abstentions and broker non-votes are counted for purposes of establishing a quorum.

    Regarding Proposal No. 1, AdvanSix’s By-laws provide that in any uncontested election of directors (an election in which the number of nominees does not exceed the number of directors to be elected), any nominee who receives a greater number of votes cast “FOR” his or her election than votes cast “AGAINST” his or her election will be elected to the Board of Directors. Shares not represented at or by proxy at the Annual Meeting of Stockholders, abstentions and broker non-votes will have no effect on the election of directors. The By-laws also provide that any incumbent director nominee who does not receive a majority of votes cast in an uncontested election is expected to promptly tender his or her resignation to the Chair of the Board following the certification of the stockholder vote. This resignation will be promptly considered through a process managed by the Nominating and Governance Committee, excluding any director nominee who did not receive a majority of votes cast to elect him or her to the Board.

    The affirmative vote of a majority of the votes cast by stockholders who are present or represented and entitled to vote on each of Proposal Nos. 2, 3, and 4 is required for approval of these proposals. Shares not represented at or by proxy at the Annual Meeting, abstentions and broker non-votes will have no effect on these proposals.

    The affirmative vote of a majority of our outstanding stock is required for approval of Proposal No. 5. Shares not represented at or by proxy at the Annual Meeting, abstentions and broker non-votes will have the effect of an “AGAINST” vote on this proposal.

    Other than as described in this Supplement, the information in the 2025 Proxy Statement remains unchanged, and this Supplement does not otherwise modify or update the 2025 Proxy Statement or the proposals to be acted upon at the Annual Meeting as described therein. From and after the date of this Supplement, any references to the “Proxy Statement” are to the 2025 Proxy Statement as supplemented by this Supplement. This Supplement should be read in conjunction with the 2025 Proxy Statement and the other proxy materials previously made available to stockholders in connection with the Annual Meeting.

    If you have already voted or directed the vote of your shares by Internet, mobile device, telephone or mail, you do not need to vote again or otherwise take any action unless you would like to change or revoke your prior vote on any proposal.

    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      11/19/24 4:20:20 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Counsel Kintiroglou Achilles B. sold $14,189 worth of shares (571 units at $24.85), decreasing direct ownership by 2% to 31,984 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/2/25 4:30:47 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Williams Patrick was granted 552 shares, increasing direct ownership by 2% to 34,193 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:42:44 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Newman Donald P was granted 977 shares, increasing direct ownership by 9% to 12,026 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:38:50 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdvanSix upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

      5/19/25 8:45:52 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

      4/7/25 8:48:39 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • Piper Sandler initiated coverage on AdvanSix with a new price target

      Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

      11/12/21 4:57:29 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    See more
    • AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

      9/12/24 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Donald P. Newman to Board of Directors

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

      8/19/24 4:30:00 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Farha Aslam to Board of Directors

      AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors. "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic prioritie

      12/14/21 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    SEC Filings

    See more
    • SEC Form 144 filed by AdvanSix Inc.

      144 - AdvanSix Inc. (0001673985) (Subject)

      7/2/25 4:49:08 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form S-8 filed by AdvanSix Inc.

      S-8 - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:20:25 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:07:25 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Financials

    Live finance-specific insights

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/13/24 4:55:58 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/9/24 9:58:57 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by AdvanSix Inc.

      SC 13G - AdvanSix Inc. (0001673985) (Subject)

      2/7/24 8:39:58 AM ET
      $ASIX
      Major Chemicals
      Industrials